CD8A and cancer: These findings reveal novel roles for the production of IL-17 as a promoter of CD8+T cells exhaustion and suggest IL-17 as a promising target for cancer immunotherapy (45), The above studies in combination with our experiments have demonstrated that cytokines such as IL-10 or IL-17 have the potential to restore the function of exhausted CD8+T cells.